METTL3 enhances the AFF4 RNA’s m6A modification and expression in bladder cancer stem cells (BCSCs), which directly controls the expression of MYC and SRY-Box Transcription Factor 2 (SOX2) in BC cells to enhance tumourigenesis in BC. This evidence concerns the gene METTL3 and urinary bladder cancer.